iCeutica's proprietary SoluMatrix Fine Particle Technology™ creates new drugs with improved efficacy, better side effect profiles and more convenient dosing.
iCeutica is advancing a pipeline of product candidates that address broad indications, including pain and inflammation, oncology, and respiratory diseases.